文献速递青光眼神经眼科

胆碱能神经系统与青光眼:从基础科学到临床应用

Cholinergic nervous system and glaucoma: From basic science to clinical applications.
PubMed 文献 · Prog Retin Eye Res · 2019-06-23

胆碱能系统在视觉功能中起关键作用,胆碱能药物作为青光眼降眼压药物备受关注,但其在神经元存活和视觉损害改善方面的潜力尚不明确。胞磷胆碱是一种天然化合物和FDA批准的膳食补充剂,近期在人类和动物模型中显示对缺血性卒中、创伤性脑损伤、帕金森病、阿尔茨海默病、脑血管疾病、记忆障碍和注意缺陷/多动障碍有效。其作用机制多样,包括保护心磷脂、鞘磷脂和花生四烯酸含量,恢复磷脂酰胆碱,刺激谷胱甘肽合成,降低谷氨酸浓度并防止谷氨酸兴奋性毒性,拯救线粒体功能从而防止氧化损伤和神经元凋亡,合成髓鞘改善神经元膜完整性,改善乙酰胆碱合成从而减少精神应激效应,以及防止内皮功能障碍。这些效应证明胞磷胆碱作为神经保护、神经修复和神经再生剂的潜力。视网膜神经节细胞是具有长髓鞘轴突的神经元,为胞磷胆碱在视觉通路疾病中的应用提供了强有力的理由。由于青光眼是涉及视网膜神经节细胞的一种神经变性,胞磷胆碱可能有助于多方面改善青光眼性损害。此外,在人类和实验性青光眼模型中已发现跨突触变性,提示胆碱能系统作为青光眼管理和治疗的新脑靶点。

要点

  • 胆碱能系统在视觉功能中起关键作用,但胆碱能药物在神经元存活和视觉损害改善方面的潜力尚不明确。
  • 胞磷胆碱是一种天然化合物和FDA批准的膳食补充剂,在人类和动物模型中显示对多种神经系统疾病有效。
  • 胞磷胆碱通过多种机制发挥神经保护、神经修复和神经再生作用,可能有助于改善青光眼性损害。

核心结论

  • 胞磷胆碱可能有助于多方面改善青光眼性损害,跨突触变性提示胆碱能系统作为青光眼管理和治疗的新脑靶点。

研究设计与样本

  • 原文未报告研究设计。

主要发现

  • 胞磷胆碱的作用机制包括保护心磷脂、鞘磷脂和花生四烯酸含量,恢复磷脂酰胆碱,刺激谷胱甘肽合成,降低谷氨酸浓度并防止兴奋性毒性,拯救线粒体功能,合成髓鞘,改善乙酰胆碱合成,防止内皮功能障碍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The cholinergic system has a crucial role to play in visual function. Although cholinergic drugs have been a focus of attention as glaucoma medications for reducing eye pressure, little is known about the potential modality for neuronal survival and/or enhancement in visual impairments. Citicoline, a naturally occurring compound and FDA approved dietary supplement, is a nootropic agent that is recently demonstrated to be effective in ameliorating ischemic stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, cerebrovascular diseases, memory disorders and attention-deficit/hyperactivity disorder in both humans and animal models. The mechanisms of its action appear to be multifarious including (i) preservation of cardiolipin, sphingomyelin, and arachidonic acid contents of phosphatidylcholine and phosphatidylethanolamine, (ii) restoration of phosphatidylcholine, (iii) stimulation of glutathione synthesis, (iv) lowering glutamate concentrations and preventing glutamate excitotoxicity, (v) rescuing mitochondrial function thereby preventing oxidative damage and onset of neuronal apoptosis, (vi) synthesis of myelin leading to improvement in neuronal membrane integrity, (vii) improving acetylcholine synthesis and thereby reducing the effects of mental stress and (viii) preventing endothelial dysfunction. Such effects have vouched for citicoline as a neuroprotective, neurorestorative and neuroregenerative agent. Retinal ganglion cells are neurons with long myelinated axons which provide a strong rationale for citicoline use in visual pathway disorders. Since glaucoma is a form of neurodegeneration involving retinal ganglion cells, citicoline may help ameliorate glaucomatous damages in multiple facets. Additionally, trans-synaptic degeneration has been identified in humans and experimental models of glaucoma suggesting the cholinergic system as a new brain target for glaucoma management and therapy.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Faiq MA, Wollstein G, Schuman JS, et al. Cholinergic nervous system and glaucoma: From basic science to clinical applications. Prog Retin Eye Res. 2019. PMID: 31242454. doi:10.1016/j.preteyeres.2019.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。